Citalopram Hydrobromide
Product Images NDC 66116-409

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Citalopram Hydrobromide (NDC 66116-409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B6052b11 A7c1 4f55 8ef5 239541c466ff 01)

Chemical structure of Citalopram Hydrobromide showing its molecular arrangement including a fluorophenyl group and a dimethylaminopropyl side chain with hydrobromide.*

FDA Label Image

Logo (B6052b11 A7c1 4f55 8ef5 239541c466ff 02)

FDA Label Image

Logo (B6052b11 A7c1 4f55 8ef5 239541c466ff 03)

Citalopram Hydrobromide 40 mg tablets carton from MedVantx, Inc. The packaging shows the product name, strength of 40 mg, dosage form as tablets, and includes manufacturer information. The package design has blue and white colors with labeling details.*

FDA Label Image

Citalopram 40mg Tablets #30 (B6052b11 A7c1 4f55 8ef5 239541c466ff 04)

Citalopram Tablets USP 40 mg label by MedVantx, Inc. The label indicates a package size of 30 tablets, storage instructions at controlled room temperature between 20°-25°C (68°-77°F) with permitted excursions. The label includes manufacturer information (Torrent Pharm. Ltd., India), a sample-only disclaimer, and a contact number for medication refills. The NDC number 66116-409-30 is visible along with directions to see the package insert for dosage details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.